RF Acquisition II (RFAI) news
Recent news
Trading released/resumed: (RFAI) Reason not available
Trading in shares of RF Acquisition Corp II (RFAI) was resumed on October 6, 2026, according to market updates. No specific reason was provided for the prior trading halt, and further details remain unavailable at this time. Investors are advised to monitor official disclosures and regulatory…
AInvest Wire · Oct 6, 2026Trading halted: (RFAI) Due to limit-up limit-down trading pause
Trading in the shares of RFAI has been temporarily suspended due to a limit-up limit-down trading pause[1]. This measure is typically implemented by exchanges to prevent excessive volatility and to allow for a more orderly market when trading activity reaches predefined thresholds. Investors are…
AInvest Wire · Oct 6, 2026The9's investee Nanyang Biologics (NYB) advancing toward Nasdaq listing after RFAI cleared vote at shareholders extraordinary general meeting
Nanyang Biologics Pte. Ltd. (NYB), a Singapore-based AI-driven drug discovery company, has taken a significant step toward a Nasdaq listing following the approval of its business combination with RF Acquisition Corp II (RFAI) at a shareholders' extraordinary general meeting. The $1.5 billion…
AInvest Wire · Aug 21, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.